Public-data shortage monitoring
FDA/openFDA shortage-change alerts that turn a noisy public feed into narrow, source-linked watchlist summaries for the drugs, categories, and manufacturers you already track.
Data source: FDA/openFDA public drug shortage records. No FDA affiliation or endorsement.
Live sample
This sample is built from real public FDA/openFDA records using the same report pipeline paid users receive: source pull, snapshot storage, drug-level grouping, public-data sorting, and watchlist-ready payloads.
Top drug-level signals
| Drug | Signal | Change score | Rows | Companies | Latest |
|---|---|---|---|---|---|
| Carboplatin InjectionOncology | high | 80 | 29 | 8 | Apr 24, 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism | high | 80 | 16 | 5 | Apr 23, 2026 |
| Methotrexate Sodium InjectionOncology, Rheumatology | high | 80 | 14 | 5 | Apr 23, 2026 |
Change score is an operational sorting label based on public-record status, reason, category, and recency. It is not a medical-importance rating.
Category pressure
Example alert
This is a public-data convenience feed, not treatment, substitution, sourcing, or inventory advice.
Webhook-ready JSON
{
"event_type": "watchlist.snapshot",
"signal": "high",
"change_score": 80,
"drug": "Carboplatin Injection",
"latest_update": "2026-04-24"
}Why choose us
FormularySignal is intentionally narrow. It watches one public source, preserves visible changes, and sends the matching records so the reader can verify them at the source.
For pharmacies, consultants, procurement teams, and operations groups that already monitor shortage feeds manually.
New records, status changes, removed records, and content changes are separated so readers do not have to scan the full feed manually.
Each paid watchlist can monitor specific drugs, categories, manufacturers, dosage forms, package NDCs, or internal keywords.
SQLite snapshots preserve what was visible at each run for source review, internal notes, and debugging.
Reports can be delivered as email, Markdown, CSV, JSON, or webhook payloads for tools the customer controls.
What changes
The FDA feed is presentation-level. FormularySignal groups those records into drug-level signals before surfacing individual package and NDC details.
Method
Fetch current public FDA/openFDA drug shortage records on a schedule.
Clean names, dates, presentation rows, package NDCs, companies, reasons, and categories.
Compare against the previous snapshot for new, removed, changed, and status-changed records.
Send watchlist-specific reports by email, CSV, JSON, or webhook.
Positioning
The goal is not to replace FDA, ASHP, clinical judgment, purchasing policy, or source verification. It is to remove the repetitive public-data check and create a clean starting point.
Trust
Records come from public FDA/openFDA drug shortage data, with source attribution preserved for review.
Reports summarize visible public-record changes and keep teams pointed back to the official source.
The product does not automate purchases, hoarding, resale, price manipulation, or patient-targeted fear marketing.
Onboarding asks for organization details and watchlist terms only. No PHI is needed for the service.
FormularySignal is not affiliated with, sponsored by, approved by, or endorsed by FDA.
Fine print: FormularySignal is an automated public-data monitoring service. No professional review is claimed. It is not medical advice, not legal advice, not inventory advice, and not FDA affiliation or endorsement. Customers should verify important records at the official source.
Pricing
For pharmacies, consultants, procurement teams, and operations groups that already monitor shortage feeds manually.
Plans renew monthly until canceled. Taxes may apply. Manage billing through the customer billing portal once production billing is configured.
Checking checkout status...
$49/mo
Monthly subscription. Auto-renews until canceled.
Daily watchlist report by email and CSV.
$199/mo
Monthly subscription. Auto-renews until canceled.
Watchlist reports plus JSON/webhook delivery.
$499/mo
Monthly subscription. Auto-renews until canceled.
Custom routing for larger watchlists and customer-owned internal workflows.
Questions buyers ask
No. FormularySignal uses public FDA/openFDA data and does not imply endorsement, approval, partnership, or sponsorship.
No. It monitors public shortage records. It does not know your wholesaler allocation, facility inventory, or supplier availability.
No. The product is intentionally designed around organization-level watchlist terms and should not receive patient data.
A watchlist-specific daily report and, on higher tiers, webhook-ready JSON/CSV for internal workflows.
Use it as a source-linked starting point for internal review. Important records should still be checked at the official source.
Public signal, not noise